The Robert Packard Center for ALS Research at Johns Hopkins
Homepage
 


June 28, 2007

SAER AND O’NEILL NAMED PACKARD CENTER BOARD CO-CHAIRS

Ushering in an era of commanding fiscal and strategic know-how, the Robert Packard Center for ALS Research at Johns Hopkins announces the appointment of two board of governors’ co-chairs: John K. Saer, Jr., a member of private equity firm Kohlberg Kravis Roberts & Co. (KKR), New York office, and Thomas P. O’Neill, president of the Financial Institutions division of life insurance giant AEGON USA, Baltimore office.

Saer is active in KKR’s industrial investments and has been involved in the firm’s chemical, technology and hospitality areas as well. Prior to joining KKR, he was chief financial officer of KSL Recreation Corporation, a KKR portfolio company.

A 25-year financial services industry veteran, O’Neill joined AEGON in 2001 as vice president; he was responsible for the distribution of all Transamerica Insurance and Investment Group’s investment, pension and insurance products through major U.S. financial institutions. A year later he became presid ent of AEGON Financial Services Group. One of the nation’s 10 largest insurance groups of its kind, AEGON leverages investment expertise and strengthens distribution relationships with large financial institutions.

With a family member living with ALS, both men support a collaborative approach to finding a cure—the Packard Center’s hallmark.

“This is a critical moment in the Center’s history,” says its director, Jeffrey Rothstein. “These two executives—well respected in their complementary fields—are careful listeners and strategic thinkers. They bring skills that will propel our organization to the next level.”


The Packard Center is a collaboration of scientists worldwide, working aggressively to develop new treatments for amyotrophic lateral sclerosis. Also known as Lou Gehrig’s disease, ALS is a progressive motor neuron disorder that causes complete paralysis and loss of function. The Center is the only institution of its kind dedicated solely to research on the disease. Its mission is to translate laboratory discoveries to the clinic as quickly as possible.



Media Contact: Liz McFarlane, 410-516-6248 or emcfarl5@gw.johnshopkins.edu
Photos available on request

For more information, call 410-516-6248 or visit www.alscenter.org.

>>more Recent News


Recent news from the Robert Packard Center for ALS Research:
William H. Adams Foundation Pumps New Energy, Funds into Search for ALS Cure - May 6, 2008
Tell-Tale Protein Clumping in ALS is Less Complex Than Expected - April 10, 2008

ALS Mouse Study Highlights Astrocytes' Strong Potential as Therapy Target - February 7, 2008

Exciting New Human ALS Trial: Lithium and Riluzole - February 7, 2008
ALS Treatment: A Matter of Cleaning House? - December 19, 2007

New Study Brings What Goes Wrong in Inherited ALS into Focus - September 18, 2007

New ALS Protein Could Be a Keystone - August 9, 2007
Muscles More Than Passive Victims in ALS, Study Suggests - June 29, 2007
Saer and O’Neill Named Packard Center Board Co-Chairs - June 28, 2007

Self-Attack? Self-Repair? First Real Look at Gene Activity in ALS Models Sparks Thirst for Answers - May 3, 2007

Model of Accelerated Familial ALS Sheds Light on Disease Process - April 6, 2007
Early News From First Large Search for Sporadic ALS Genes - February 20, 2007
Human Stem Cell Transplants Mature Into Neurons and Make Contacts in Rat Spinal Cord - February 14, 2007

First Vaccine for Familial ALS Shows Potential in Model Mice - January 29, 2007

Our Five-Year Plan? Let Human Cells EXcellerate Therapy - January 18, 2007




Enter your e-mail address to
join the free ALS News Network!

Johns Hopkins Medicine

Alzheimer's Association ABC2 Robert Packard Center for ALS Research